The Future Targeted Healthcare Manufacturing Hub’s research is supported by a User Steering Committee of over 35 industrial users and sector organisations to revolutionise the delivery of cost-effective stratified protein-based and personalised cell-based therapies to patients. The Hub User Steering Committee provides advice and guidance on the overall direction and progress of the Hub research.
The Hub User Steering Committee has 5 Specialist Working Groups (SWGs) to provide more detailed advice and direction on specific elements of the research: decisional tools, cell free synthesis, T-cell processing, formulation and healthcare.
Hub User Steering Committee Members*:
Companies: Albumedix, Allergan, AstraZeneca/ MedImmune, Autolus, BIA Separations, BiologicB, BioPharm Services, DeltaDot, Eli Lilly, Francis BioPharm Consulting, Fujifilm Diosynth Biotechnologies, GSK, Ipsen, Lonza, Merck KGaA, Oracle, Oxford BioMedica, Pall, Perceptive, Puridify, Purolite, ReNeuron, Roche, Sartorius, Sutro Biopharma, Tillingbourne Consulting, TrakCel, UCB, West Pharma, Wyatt. Industry/Govt Associations: ABPI, BIA, KTN, LGC, MMIP, NIBSC. Translational Spokes: CGTC, CPI/NBMC
* Signed or in the process of signing the Collaboration agreement as of November 2017